US Poison Control Center Calls for Infants 6 Months of Age and Younger

A Min Kang1, Daniel E Brooks2

  • 1Department of Medical Toxicology and Banner Poison and Drug Information Center, Banner-University Medical Center Phoenix; and Center for Toxicology and Pharmacology Education and Research, University of Arizona College of Medicine, Phoenix; Arizona aaron.kang@bannerhealth.com.

Pediatrics
|January 15, 2016
PubMed

Insights

Therapeutic errors and general unintentional exposures are common in infants under six months. Dosing errors, both quantitative and nonquantitative, are significant concerns requiring targeted prevention strategies.

Area of Science:

  • Pediatric Toxicology
  • Public Health
  • Emergency Medicine

Background:

  • Poisoning prevention in young children traditionally focuses on restricting access to hazardous substances.
  • Infants under six months, due to limited mobility, are less prone to exploratory ingestions but more susceptible to medication-related errors.
  • The epidemiology of poison exposures in this vulnerable age group is not well-defined, potentially limiting the effectiveness of current prevention strategies.

Purpose of the Study:

  • To characterize the epidemiology of poison exposures in infants aged 0-6 months.
  • To identify the primary causes of these exposures, differentiating between general unintentional ingestions and therapeutic errors.
  • To inform the development of targeted anticipatory guidance and prevention measures for this age group.

Main Methods:

  • A retrospective analysis of 10-year (2004-2013) exposure data was conducted.
  • Data were sourced from the National Poison Data System, focusing on infants up to 6 months of age.
  • Exposure calls were categorized by reason, including general unintentional and therapeutic errors.

Main Results:

  • Over 271,000 exposures were reported, with 96.7% being unintentional.
  • General unintentional exposures accounted for 50.7%, while therapeutic errors represented 36.7% of cases.
  • Within therapeutic errors, quantitative (47.0%) and nonquantitative (42.8%) dosing errors were nearly equally prevalent.

Conclusions:

  • Both general unintentional ingestions and therapeutic errors are significant contributors to poison exposures in infants under six months.
  • Quantitative and nonquantitative dosing errors represent equally critical issues within therapeutic errors.
  • A notable proportion of affected infants present to healthcare facilities before consulting a poison center, highlighting a gap in initial management and guidance.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
76
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
150
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372